Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnes E M Looijen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Rheumatology|March 5, 2025
Sex Differences in Rheumatoid Arthritis: New Insights From Clinical and Patient-Reported Outcome PerspectivesGonul Hazal Koc, Agnes E M Looijen, Irene E van der Horst-Bruinsma, et al.
Rheumatology (Oxford, England)|March 10, 2022
Tapering subcutaneous methotrexate causes more disease flares compared with tapering oral administration in established rheumatoid arthritis patientsAgnes E M Looijen, Elise van Mulligen, Annette H M van der Helm-van Mil, et al.
RMD Open|July 20, 2024
Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis?Judith W Heutz, Agnes E M Looijen, Annette H M van der Helm-van Mil, et al.
Rheumatology (Oxford, England)|August 26, 2023
Patients with rheumatoid arthritis presenting with mono- or oligo-arthritis and high VAS-ratings remain the most fatigued during 5 years of follow-upAnna M P Boeren, Marloes Verstappen, Agnes E M Looijen, et al.
Rheumatology (Oxford, England)|April 4, 2024
Responsiveness and sensitivity of PROMs to change in disease activity status in early and established rheumatoid arthritisAgnes E M Looijen, Elise van Mulligen, Harald E Vonkeman, et al.
RMD Open|February 21, 2024
Patient-reported outcomes and radiographic progression in patients with rheumatoid arthritis in sustained remission versus low disease activitySelinde V J Snoeck Henkemans, Marijn Vis, Agnes E M Looijen, et al.
Annals of the Rheumatic Diseases|December 18, 2025
Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritisAgnes E M Looijen, Paco M J Welsing, Sytske Anne Bergstra, et al.
Rheumatology (Oxford, England)|August 12, 2025
Eye-openers for advanced management of elderly-onset rheumatoid arthritisHamit Harun Dag, Selinde V J Snoeck Henkemans, Agnes E M Looijen, et al.
Medical Education|August 14, 2020
Stereoscopic three-dimensional visualisation technology in anatomy learning: A meta-analysisKaterina Bogomolova, Beerend P Hierck, Agnes E M Looijen, et al.
Immunologic Research|July 3, 2024
The prognostic value of IgA anti-citrullinated protein antibodies and rheumatoid factor in an early arthritis population with a treat-to-target approachJudith W Heutz, Agnes E M Looijen, Jac H S A M Kuijpers, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Rheumatology|March 5, 2025
Sex Differences in Rheumatoid Arthritis: New Insights From Clinical and Patient-Reported Outcome PerspectivesGonul Hazal Koc, Agnes E M Looijen, Irene E van der Horst-Bruinsma, et al.
Rheumatology (Oxford, England)|March 10, 2022
Tapering subcutaneous methotrexate causes more disease flares compared with tapering oral administration in established rheumatoid arthritis patientsAgnes E M Looijen, Elise van Mulligen, Annette H M van der Helm-van Mil, et al.
RMD Open|July 20, 2024
Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis?Judith W Heutz, Agnes E M Looijen, Annette H M van der Helm-van Mil, et al.
Rheumatology (Oxford, England)|August 26, 2023
Patients with rheumatoid arthritis presenting with mono- or oligo-arthritis and high VAS-ratings remain the most fatigued during 5 years of follow-upAnna M P Boeren, Marloes Verstappen, Agnes E M Looijen, et al.
Rheumatology (Oxford, England)|April 4, 2024
Responsiveness and sensitivity of PROMs to change in disease activity status in early and established rheumatoid arthritisAgnes E M Looijen, Elise van Mulligen, Harald E Vonkeman, et al.
RMD Open|February 21, 2024
Patient-reported outcomes and radiographic progression in patients with rheumatoid arthritis in sustained remission versus low disease activitySelinde V J Snoeck Henkemans, Marijn Vis, Agnes E M Looijen, et al.
Annals of the Rheumatic Diseases|December 18, 2025
Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritisAgnes E M Looijen, Paco M J Welsing, Sytske Anne Bergstra, et al.
Rheumatology (Oxford, England)|August 12, 2025
Eye-openers for advanced management of elderly-onset rheumatoid arthritisHamit Harun Dag, Selinde V J Snoeck Henkemans, Agnes E M Looijen, et al.
Medical Education|August 14, 2020
Stereoscopic three-dimensional visualisation technology in anatomy learning: A meta-analysisKaterina Bogomolova, Beerend P Hierck, Agnes E M Looijen, et al.
Immunologic Research|July 3, 2024
The prognostic value of IgA anti-citrullinated protein antibodies and rheumatoid factor in an early arthritis population with a treat-to-target approachJudith W Heutz, Agnes E M Looijen, Jac H S A M Kuijpers, et al.
Pageof 2